Literature DB >> 31161915

Phenomenology and Course of Alcoholic Hallucinosis.

Venkata Lakshmi Narasimha1, Rahul Patley2, Lekhansh Shukla2, Vivek Benegal1, Arun Kandasamy1.   

Abstract

Objective: The objective of the study was to examine the correlates, phenomenology, and short-term treatment response to benzodiazepines and antipsychotics in an inpatient sample with alcohol-induced psychotic disorder, predominant hallucinations i.e., F10.52.
Methods: We reviewed the charts of the patients admitted in a tertiary care addiction treatment center between 2010 and 2016 with the diagnosis of alcoholic hallucinosis.
Results: Among 6,493 patients admitted with alcohol dependence during the study period, 61 patients (0.9%) had alcoholic hallucinosis. Among them, 41 (67.2%) had alcoholic hallucinosis in the past; 26 (42.6%) had a family history of psychosis. Only auditory hallucinations were found in 46 patients (75.4%), only visual hallucinations in 3 patients (5%), and both auditory and visual hallucinations in 12 (19.7%). Thirty-four (55.7%) had delusions, which were secondary to hallucinations. Suicidality which includes suicidal ideas and attempts was noted in 12 (19.7%) patients. Fifty-three (86.9%) patients had hallucinations exclusively during alcohol withdrawal, while 8 (13.1%) had them during withdrawal as well as while consuming alcohol. At the end of six months, 13.1% of the patients had an independent psychotic disorder diagnosed. The primary mode of management was treatment with only benzodiazepines (n = 37, 60.7%) or benzodiazepines and antipsychotics (n = 24, 39.3%). The reasons for starting antipsychotics were the presence of florid psychotic symptoms (26.2%) and incomplete symptom resolution with benzodiazepines (9.8%). The median duration of response was four days, with 25th to 75th quartile range at two to seven days. Conclusions: Alcoholic hallucinosis is an acute short-lasting psychotic disorder which lasts for less than a week when treated. Suicidality is high in this group, which needs attention. Benzodiazepines as part of withdrawal management may be sufficient for a majority of cases. Antipsychotics may be required in selected cases. A high degree of recurrence and morbidity indicates a need to intervene early with an abstinence-oriented management goal.

Entities:  

Keywords:  Alcohol; antipsychotics; benzodiazepines; hallucinosis; suicide

Mesh:

Substances:

Year:  2019        PMID: 31161915     DOI: 10.1080/15504263.2019.1619008

Source DB:  PubMed          Journal:  J Dual Diagn        ISSN: 1550-4271


  3 in total

1.  Correlation of 1846G>A Polymorphism of CYP2D6 Gene with Haloperidol Efficacy and Safety in Patients with Alcoholic Hallucinoses.

Authors:  A A Parkhomenko; M S Zastrozhin; VYu Skryabin; V A Ivanchenko; S A Pozdniakov; V V Noskov; I A Zaytsev; N P Denisenko; K A Akmalova; E A Bryun; D A Sychev
Journal:  Psychopharmacol Bull       Date:  2022-06-27

2.  Complicated Alcohol Withdrawal-An Unintended Consequence of COVID-19 Lockdown.

Authors:  Venkata Lakshmi Narasimha; Lekhansh Shukla; Diptadhi Mukherjee; Jayakrishnan Menon; Sudheendra Huddar; Udit Kumar Panda; Jayant Mahadevan; Arun Kandasamy; Prabhat K Chand; Vivek Benegal; Pratima Murthy
Journal:  Alcohol Alcohol       Date:  2020-06-25       Impact factor: 2.826

3.  Charles Bonnet Syndrome in the Setting of a Traumatic Brain Injury.

Authors:  Ricardo Irizarry; Ariel Sosa Gomez; Jean Tamayo Acosta; Leonel Gonzalez Diaz
Journal:  Cureus       Date:  2022-09-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.